Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released May 8, 2012, after the close
10-Q filed May 8, 2012, 38 days after period end · 0001193125-12-218369
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $450.00K | $435.00K |
| Net Income | -$6.22M | -$5.83M |
| EPS Diluted | -$0.12 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 8, 2012 · 38 d after period end
